Here’s a roundup of the latest coronavirus-related news.
Pfizer-BioNTech Releases Newest Topline Data for COVID-19 Vaccine
Pfizer and BioNTech announced topline results from an analysis spanning through March 13, which in part showed their COVID-19 vaccine to be 91.3% effective against the virus for up to 6 months after the second dose.
Pfizer-BioNTech COVID-19 Vaccine Shows High Efficacy in Adolescents
Pfizer/BioNTech has just released their topline data from their Phase 3 study of participants aged 12 to 15 years.
Analysis: The Effect of Remote Immunization Screenings on Vaccine Uptake
A retrospectively analysis assessed the effect of a remote vaccination review process on vaccination status during the COVID-19 pandemic.
Moderna, Pfizer Vaccines Safe and Effective in Pregnant, Lactating Women
A team of researchers have released study results that show the Moderna and Pfizer vaccines are indeed safe and effective for this population.
Prime Therapeutics Boosts COVID-19 Vax Administration Fees To Match What CMS Is Paying
The Minnesota PBM says it will pay $40 for a single-dose vaccine and $80 for a two-dose one. The company says it has paid pharmacies a total of $29 million in COVID-19 vaccine administration fees so far.
How Does Digital Data Help Improve QOL in Patients With Long COVID and Autoimmune Diseases?May 30th 2023
Quality of life (QOL) for people living with autoimmune diseases benefits from an integrated approach that considers individual immune system sensitivities and patients’ life circumstances, a new study shows.
2 Clarke Drive
Cranbury, NJ 08512